News Headlines Article

Cancer centers claim Genentech shipped less cancer drug Herceptin than promised
San Francisco Business Times

Nine cancer care centers in seven states claim in a flurry of lawsuits that Genentech Inc. shipped less of its popular breast cancer-fighting drug Herceptin than labeled. The suits, filed in New York, Texas, Florida, Virginia, Tennessee, Minnesota and Oklahoma, say vials of freeze-dried Herceptin when mixed with a liquid failed to produce the correct concentration of the drug, causing the cancer care centers to buy additional vials.